23andMe Holding Co (ME)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Anne Wojcicki
Employees:
666
899 W. EVELYN AVENUE, Mountain View, CA 94041
(650) 938-6300

23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, 23andMe's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world's largest crowdsourced platform for genetic research, with 80% of its customers electing to participate.

Data derived from most recent annual or quarterly report
Market Cap 1.011 Billion Shares Outstanding93.027 Million Avg 30-day Volume 3.199 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 13.55 / 7.01 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from ME instead.

View recent insider trading info

Funds Holding ME (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ME BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHELLER RICHARD H

  • Director
18,421 2021-09-14 2

BOTHA ROELOF

  • Director
  • 10% Owner
18,421 2021-09-14 2

LOVELL EVAN

  • Director
18,421 2021-09-14 1

TAYLOR PETER J.

  • Director
55,263 2021-09-14 2

MONTGOMERY RICE VALERIE MD

  • Director
55,263 2021-09-14 2

MOHAN NEAL

  • Director
18,421 2021-09-14 2

CHUNG PATRICK S

  • Director
18,421 2021-09-14 2

SC US (TTGP), LTD.

SC GLOBAL GROWTH II MANAGEMENT, L.P.

SEQUOIA CAPITAL GLOBAL GROWTH FUND II, L.P.

SEQUOIA CAPITAL GLOBAL GROWTH II PRINCIPALS FUND, L.P.

LEONE DOUGLAS M

BOTHA ROELOF

SEQUOIA GROVE MANAGER, LLC

SEQUOIA GROVE II, LLC

  • 10% Owner
0 2021-06-16 1

HIBBS KATHY L SEE REMARKS

  • Officer
0 2021-06-16 1

SC US (TTGP), LTD.

SC U.S. GROWTH VII MANAGEMENT, L.P.

SEQUOIA CAPITAL U.S. GROWTH FUND VII, L.P.

SEQUOIA CAPITAL U.S. GROWTH VII PRINCIPALS FUND, L.P.

SCGF III MANAGEMENT LLC

SEQUOIA CAPITAL GROWTH FUND III

SC U.S. GROWTH VIII MANAGEMENT, L.P.

SEQUOIA CAPITAL U.S. GROWTH FUND VIII, L.P.

  • 10% Owner
0 2021-06-16 1

HILLAN KENNETH J. HEAD OF THERAPEUTICS

  • Officer
0 2021-06-16 1

WOJCICKI ANNE CHIEF EXECUTIVE OFFICER

ABEEC 2.0, LLC

  • Officer
  • Director
  • 10% Owner
3,750,581 2021-06-16 1

KOHLER FREDERICK MARK VICE PRESIDENT, PEOPLE

  • Officer
0 2021-06-16 1

SCHOCH STEVEN J SEE REMARKS

  • Officer
0 2021-06-16 1

LEMON STEVEN VICE PRESIDENT, ENGINEERING

  • Officer
0 2021-06-16 1

KEIM TRACY SEE REMARKS

  • Officer
0 2021-06-16 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BOTHA ROELOF - Director - > 10% Owner

2021-09-16 16:12:38 -0400 2021-09-14 A 18,421 a 18,421 direct 4.3165 11.271 11.271 6 0.0 1

TAYLOR PETER J. - Director

2021-09-16 16:27:19 -0400 2021-09-14 A 18,421 a 55,263 direct 4.3165 11.271 11.271 6 0.0 1

MONTGOMERY RICE VALERIE MD - Director

2021-09-16 16:23:19 -0400 2021-09-14 A 36,842 a 36,842 direct 4.3165 11.271 11.271 6 0.0 1

CHUNG PATRICK S - Director

2021-09-16 16:14:04 -0400 2021-09-14 A 18,421 a 18,421 direct 4.3165 11.271 11.271 6 0.0 1

TAYLOR PETER J. - Director

2021-09-16 16:27:19 -0400 2021-09-14 A 36,842 a 36,842 direct 4.3165 11.271 11.271 6 0.0 1

SCHELLER RICHARD H - Director

2021-09-16 16:24:30 -0400 2021-09-14 A 18,421 a 18,421 direct 4.3165 11.271 11.271 6 0.0 1

LOVELL EVAN - Director

2021-09-16 16:15:54 -0400 2021-09-14 A 18,421 a 18,421 direct 4.3165 11.271 11.271 6 0.0 1

MONTGOMERY RICE VALERIE MD - Director

2021-09-16 16:23:19 -0400 2021-09-14 A 18,421 a 55,263 direct 4.3165 11.271 11.271 6 0.0 1

MOHAN NEAL - Director

2021-09-16 16:17:12 -0400 2021-09-14 A 18,421 a 18,421 direct 4.3165 11.271 11.271 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
23ANDME HOLDING CO -CLASS A ME 2021-10-22 19:15:03 UTC -24.3442 24.4142 200
23ANDME HOLDING CO -CLASS A ME 2021-10-22 18:45:03 UTC -24.3442 24.4142 50
23ANDME HOLDING CO -CLASS A ME 2021-10-22 18:15:03 UTC -24.3442 24.4142 50
23ANDME HOLDING CO -CLASS A ME 2021-10-22 17:45:03 UTC -24.3442 24.4142 50
23ANDME HOLDING CO -CLASS A ME 2021-10-22 17:15:03 UTC -24.3442 24.4142 50
23ANDME HOLDING CO -CLASS A ME 2021-10-22 16:45:03 UTC -24.3442 24.4142 25
23ANDME HOLDING CO -CLASS A ME 2021-10-22 15:45:03 UTC -24.3442 24.4142 200
23ANDME HOLDING CO -CLASS A ME 2021-10-22 15:15:03 UTC -24.3442 24.4142 1000
23ANDME HOLDING CO -CLASS A ME 2021-10-22 14:45:03 UTC -28.6242 28.6942 2000
23ANDME HOLDING CO -CLASS A ME 2021-10-22 14:15:03 UTC -28.6242 28.6942 6000
23ANDME HOLDING CO -CLASS A ME 2021-10-22 13:45:03 UTC -28.6242 28.6942 6000
23ANDME HOLDING CO -CLASS A ME 2021-10-22 13:15:03 UTC -28.6242 28.6942 6000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 22:15:02 UTC -28.6242 28.6942 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 21:45:03 UTC -29.2602 29.3302 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 21:15:04 UTC -29.2602 29.3302 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 20:45:03 UTC -29.7867 29.8567 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 20:15:03 UTC -29.7867 29.8567 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 19:45:03 UTC -29.7867 29.8567 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 19:15:02 UTC -29.7867 29.8567 20000
23ANDME HOLDING CO -CLASS A ME 2021-10-21 18:45:03 UTC -28.7959 28.8659 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments